Michael J Kozal MD
Professor of Medicine (AIDS); Chief Section of Infectious Diseases VA CT Healthcare System; Director Yale HIV Clinical Trials; Acting Chief, Medical Service VACHS & Vice Chair, VA Medical Service for the Yale Dept. of Internal Medicine
Departments & Organizations
Genetic determinants of HIV and Hepatitis C drug resistance; New technologies to detect low abundance drug resistant viral variants more...
- M.D., University of Nebraska, 1988
- Zou Xiaobai, Chen Xi, Tian H, Williams AB, Wang H, He J, Zhen J, Chiarella J, and Kozal MJ. Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China. PLoS One. 2014 Jun 4;9(6):e98740. doi: 10.1371/journal.pone.0098740
- Chabria S, Gupta S and Kozal MJ. Deep Sequencing of HIV: clinical and research applications. Annual Review of Genomics and Human Genetics. 2014 May 9. [Epub ahead of print] PMID: 24821496
- Li JZ, Paredes R, Ribaudo H, Kozal MJ, Svarovskaia ES, Johnson JA, Geretti AM, Metzner KJ, Jakobsen M, Huppler Hullsiek K, Ostergaard L, Miller MD, and Kuritzkes DR. Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype after Virologic Failure. Journal of Infectious Diseases, 2013 Mar;207(6):893-7. PMID:23264671